Tris Savings Program

Tris Pharma Co-pay Savings Program

Eligible Patients may save on their out-of-pocket costs for Dyanavel XR, Quillivant XR, QuilliChew ER or Onyda XR

DYANAVEL XR TABLET

DYANAVEL XR TABLET Get my savings card

DYANAVEL XR LIQUID
QUILLIVANT XR LIQUID
QUILLICHEW ER TABLET

Tris Savings Card Example Get my savings card

ONYDA XR LIQUID

ONYDA XR TABLET Get my savings card

*With the Tris Co-pay Savings Card, eligible commercially-insured and cash-paying patients can lower their out-of-pocket costs for their prescription. Eligible patients may pay as little as $25 on each prescription. Program benefit calculated on FDA-approved dosing. A valid Prescriber ID# is required on the prescription. Patients with questions about the Tris Savings offer should call 1-888-840-7006. Terms and Conditions available at coupon.trisadhd.com/terms.

APPROVED USE

DYANAVEL XR, Quillivant XR, and QuilliChew ER are central nervous system (CNS) stimulant prescription medicines used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in people 6 years and older. These medicines may help increase attention and decrease impulsiveness and hyperactivity in people with ADHD.

It is not known if DYANAVEL XR, Quillivant XR, and QuilliChew ER are safe and effective in children under 6 years of age.

IMPORTANT SAFETY INFORMATION

DYANAVEL XR, Quillivant XR, and QuilliChew ER are federally controlled substance (CII) because they can be a target for people who abuse prescription medicines or street drugs. DYANAVEL XR, Quillivant XR, and QuilliChew ER has a high chance for abuse and misuse and may lead to substance use problems, including addiction. Keep these medicines in a safe place to prevent abuse and misuse. Selling or giving away these medicines may harm others and is against the law.

Your healthcare provider should check you or your child’s risk for abuse, misuse, and addiction before starting treatment with DYANAVEL XR, Quillivant XR, and QuilliChew ER and will monitor you or your child during treatment. Tell your physician if you, your child, or any family members have ever abused or been dependent on alcohol, prescription medicines, or street drugs.

DYANAVEL XR, or Quillivant XR and QuilliChew ER, should not be taken if you or your child are allergic to amphetamine or methylphenidate hydrochloride, respectively, or any of the ingredients in these medicines, or are taking or have taken within the past 14 days an anti-depression medicine called a monoamine oxidase inhibitor or MAOI including the antibiotic linezolid and the intravenous medicine methylene blue.

DYANAVEL XR, Quillivant XR, and QuilliChew ER can cause serious side effects. Tell the doctor:

Common side effects of amphetamine products include:

  • dry mouth
  • decreased appetite
  • weight loss
  • stomach pain
  • nausea
  • trouble sleeping
  • restlessness
  • extreme mood changes
  • dizziness
  • increased heart rate
  • dry mouth
  • decreased appetite
  • weight loss
  • stomach pain
  • nausea
  • trouble sleeping
  • restlessness
  • extreme mood changes
  • dizziness
  • increased heart rate

Common side effects of methylphenidate products include:

  • decreased appetite
  • trouble sleeping
  • nausea
  • vomiting
  • indigestion
  • stomach pain
  • weight loss
  • anxiety
  • dizziness
  • irritability
  • mood swings
  • fast heart beat
  • increased blood pressure
  • decreased appetite
  • trouble sleeping
  • nausea
  • vomiting
  • indigestion
  • stomach pain
  • weight loss
  • anxiety
  • dizziness
  • irritability
  • mood swings
  • fast heart beat
  • increased blood pressure

Talk to your doctor if you or your child have any side effects that bother you or do not go away.

Avoid drinking alcohol while taking DYANAVEL XR, Quillivant XR, or QuilliChew ER.

To report SUSPECTED ADVERSE REACTTIONS, contact Tris Pharma, Inc. at (732) 940-0358 or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

See Full Prescribing Information for Dyanavel XR, Quillivant XR, and QuilliChew ER, including Boxed Warning about Abuse, Misuse and Addiction.

APPROVED USE

ONYDA™ XR is a prescription medicine used for the treatment of attention deficit hyperactivity disorder (ADHD) alone or with certain other ADHD medicines in children 6 years of age and older.

It is not known if ONYDA XR is safe and effective in children under 6 years of age.

IMPORTANT SAFETY INFORMATION

Who should not take ONYDA XR?
Do not take ONYDA XR if you are allergic to clonidine.

ONYDA XR can cause serious side effects, including:

The most common side effects of ONYDA XR when used alone include:

  • falling asleep or sleepiness and tiredness that could cause slow reaction times
  • irritability
  • nightmares
  • trouble sleeping
  • constipation
  • dry mouth
  • falling asleep or sleepiness and tiredness that could cause slow reaction times
  • irritability
  • nightmares
  • constipation
  • dry mouth

The most common side effects of ONYDA XR when used with other ADHD medicines include:

  • falling asleep or sleepiness and tiredness that could cause slow reaction times
  • decreased appetite
  • dizziness
  • falling asleep or sleepiness and tiredness that could cause slow reaction times
  • decreased appetite
  • dizziness

ONYDA XR may cause fertility problems in females and males, which may affect your ability to have a child. Talk to your healthcare provider if this is a concern for you. These are not all of the possible side effects of ONYDA XR. Call your doctor for medical advice about side effects.

ONYDA XR and certain other medicines may affect each other, causing serious side effects. Especially tell your healthcare provider if you take:

  • antidepression medicines
  • heart or blood pressure medicines
  • other medicines for ADHD
  • other medicines that contain clonidine
  • medicines that cause sleepiness (sedation)
  • antidepression medicines
  • heart or blood pressure medicines
  • other medicines for ADHD
  • other medicines that contain clonidine
  • medicines that cause sleepiness (sedation)

Ask your healthcare provider or pharmacist if you are not sure if your medicine is listed above. Know the medicines that you take. Keep a list of your medicines with you to show your healthcare provider and pharmacist when you get a new medicine.

Before taking ONYDA XR, tell your healthcare provider, if you:

  • Are pregnant or plan to become pregnant. It is not known if ONYDA XR will harm the unborn baby.
  • Are pregnant or plan to become pregnant. It is not known if ONYDA XR will harm the unborn baby.

There is a pregnancy registry for females who are exposed to ADHD medications, including ONYDA XR, during pregnancy. The purpose of the registry is to collect information about the health of females exposed to ONYDA XR and their baby. If you become pregnant during treatment with ONYDA XR, talk to your healthcare provider about registering with the National Pregnancy Registry of ADHD Medications at 1-866-961-2388 or visit online at https://womensmentalhealth.org/adhdmedications/

  • Are breastfeeding or plan to breastfeed. ONYDA XR passes into the breast milk. Babies who are breastfed during treatment with ONYDA XR may become very sleepy, develop relaxed or floppy muscles, and develop trouble breathing. Call the baby’s healthcare provider if the baby is breastfed during treatment with ONYDA XR and develops any of these symptoms. Talk to your healthcare provider about the best way to feed your baby if you take ONYDA XR.
  • Are breastfeeding or plan to breastfeed. ONYDA XR passes into the breast milk. Babies who are breastfed during treatment with ONYDA XR may become very sleepy, develop relaxed or floppy muscles, and develop trouble breathing. Call the baby’s healthcare provider if the baby is breastfed during treatment with ONYDA XR and develops any of these symptoms. Talk to your healthcare provider about the best way to feed your baby if you take ONYDA XR.

Talk to your doctor if you or your child have any side effects that bother you or do not go away.

To report side effects, contact Tris Pharma, Inc. at 1-732-940-0358 or the FDA at www.fda.gov/medwatch or 1-800-FDA-1088.

Please see ONYDA Prescribing Information for full prescribing information, including patient information and instructions for use.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare professional. All decisions regarding patient care must be made with a healthcare professional, considering the unique characteristics of the patient.

This site is intended solely for US residents and is governed solely by US laws and government regulations. Please see our online privacy policy for more information. While Tris Pharma makes reasonable efforts to include accurate, up-to-date information on the site, Tris Pharma makes no warranties or representations as to its accuracy. Tris Pharma assumes no liability for any errors or omissions in the content of the site.

DYANAVEL XR is a registered trademark of Tris Pharma, Inc. ONYDA XR is a trademark of Tris Pharma Inc. Quillivant XR and QuilliChew ER are registered trademarks of NextWave Pharmaceuticals Inc. © 2024 Tris Pharma, Inc. All rights reserved. DXR.2642.PR      9/24